Back to search resultsSummaryRMgm-4426
|
Successful modification | The parasite was generated by the genetic modification |
The mutant contains the following genetic modification(s) | Gene tagging |
Reference (PubMed-PMID number) |
Reference 1 (PMID number) : 29487181 |
MR4 number | |
top of page | |
Parent parasite used to introduce the genetic modification | |
Rodent Malaria Parasite | P. yoelii |
Parent strain/line | P. y. yoelii 17XNL |
Name parent line/clone | Not applicable |
Other information parent line | |
top of page | |
The mutant parasite was generated by | |
Name PI/Researcher | Liang X, Lindner SE, Cui L |
Name Group/Department | Department of Entomology |
Name Institute | Pennsylvania State University |
City | University Park |
Country | USA |
top of page | |
Name of the mutant parasite | |
RMgm number | RMgm-4426 |
Principal name | PyPuf3::GFP |
Alternative name | |
Standardized name | |
Is the mutant parasite cloned after genetic modification | Yes |
top of page | |
Phenotype | |
Asexual blood stage | Nuclear, nucleolar location of GFP-tagged Puf3 in blood stages. |
Gametocyte/Gamete | Not tested |
Fertilization and ookinete | Not tested |
Oocyst | Puf3 changed its localization in mosquito and liver stages from nucleolar to cytosolic puncta. After transmission of the transgenic parasite line to mosquitoes, PyPuf3::GFP was observed to be concentrated into banded foci in the developing oocysts. When sporozoites were dissected from the developing oocysts on day 10, PyPuf3::GFP was found in punctate foci of the oocyst sporozoites. The PyPuf3::GFP foci were not observed in mature salivary gland sporozoites. |
Sporozoite | Puf3 changed its localization in mosquito and liver stages from nucleolar to cytosolic puncta. After transmission of the transgenic parasite line to mosquitoes, PyPuf3::GFP was observed to be concentrated into banded foci in the developing oocysts. When sporozoites were dissected from the developing oocysts on day 10, PyPuf3::GFP was found in punctate foci of the oocyst sporozoites. The PyPuf3::GFP foci were not observed in mature salivary gland sporozoites. |
Liver stage | Puf3 changed its localization in mosquito and liver stages from nucleolar to cytosolic puncta. During mid-liver stage development (24 h), large foci containing PyPuf3::GFP were visible, and they were adjacent to DAPI stained DNA but had minimal overlap. However, in late (48 h) liver stage schizonts, PyPuf3::GFP expression was not detectable. |
Additional remarks phenotype | Mutant/mutation Phenotype |
top of page | |||||||||||||||||||||||||||
Details of the target gene | |||||||||||||||||||||||||||
Gene Model of Rodent Parasite | PY17X_1121600 | ||||||||||||||||||||||||||
Gene Model P. falciparum ortholog | PF3D7_0621300 | ||||||||||||||||||||||||||
Gene product | mRNA-binding protein PUF3 | ||||||||||||||||||||||||||
Gene product: Alternative name | PUF3 | ||||||||||||||||||||||||||
top of page | |||||||||||||||||||||||||||
Details of the genetic modification | |||||||||||||||||||||||||||
Name of the tag | GFP | ||||||||||||||||||||||||||
Details of tagging | C-terminal | ||||||||||||||||||||||||||
Additional remarks: tagging | |||||||||||||||||||||||||||
Commercial source of tag-antibodies | |||||||||||||||||||||||||||
Type of plasmid/construct | (Linear) plasmid double cross-over | ||||||||||||||||||||||||||
PlasmoGEM (Sanger) construct/vector used | No | ||||||||||||||||||||||||||
Modified PlasmoGEM construct/vector used | No | ||||||||||||||||||||||||||
Plasmid/construct map | |||||||||||||||||||||||||||
Plasmid/construct sequence | |||||||||||||||||||||||||||
Restriction sites to linearize plasmid | |||||||||||||||||||||||||||
Selectable marker used to select the mutant parasite | hdhfr | ||||||||||||||||||||||||||
Promoter of the selectable marker | unknown | ||||||||||||||||||||||||||
Selection (positive) procedure | pyrimethamine | ||||||||||||||||||||||||||
Selection (negative) procedure | No | ||||||||||||||||||||||||||
Additional remarks genetic modification | |||||||||||||||||||||||||||
Additional remarks selection procedure | |||||||||||||||||||||||||||
| |||||||||||||||||||||||||||
top of page |